Enfusion, Clearwater

Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker ...
DA Davidson upgraded Clearwater Analytics (CWAN) to Buy from Neutral with a price target of $32, down from $35. The company’s proposed merger ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 22.42% ...
GAMMA Investing LLC raised its stake in shares of Clearwater Analytics Holdings, Inc. (NYSE:CWAN – Free Report) by 57.4% ...
RBC Capital lowered the firm’s price target on Clearwater Analytics (CWAN) to $30 from $36 but keeps an Outperform rating on the shares after ...